Ved IKOM skjer basal-, klinisk-, og translasjonsforskning innen brede medisinske fagområder. Undervisning og forskning for bedre helse.
Trondheim, Norway
Joined April 2020
- Tweets352
- Following193
- Followers290
- Likes109
For tidlig fødte har økt risiko for #KOLS og #astma, viser studier fra Norge @ntnuhelse og Finland @OYS_sairaala @THLorg gemini.no/2023/06/for-tidlig…
We have a vacancy for a PhD candidate who will be part of designing and running a clinical trial on #PrecisionMedicine, where we make use of #ColonCancer lab cultivated cells for therapy selection jobbnorge.no/en/available-jo… @NTNUikom @asmundflobak @Kreftforeningen
NTNU Klinisk og Molekylær Medisin retweeted
Are you interested in a PhD position on functional preicision medicine for colon cancer?
See our PhD application: jobbnorge.no/en/available-jo…
Funded @Kreftforeningen @forskningsradet via @fkbmatrix. @NTNU @HellandAslaug @KjetilTasken @HRussnes @evhofs @TheSFPM @StOlavshospital
Førsteamanuensis Michael Due Larsen, universitetslektor Espen S. Kolberg og kolleger lanserte denne uka læreboken «Kasuistikker i klinisk farmasi», en lærebok som beskriver den kliniske farmasøytens rolle i det tverrfaglige teamet rundt pasienten. Vi gratulerer med utgivelsen!
NTNU Klinisk og Molekylær Medisin retweeted
Acne, irregular periods, high amount of body hair, does it sound familiar? If you have polycystic ovary syndrome (#PCOS), this is of interest to you.
We are conducting a clinical trial to test a novel treatment for PCOS in 7⃣hospitals across 🇪🇺.
🔗👉spiomet4health.eu/the-clinic…
In Norway, the burden of invasive group B streptococcal infection during infancy is considerable and continues to affect children well beyond infancy. onlinelibrary.wiley.com/doi/… @Marenmi2
NTNU Klinisk og Molekylær Medisin retweeted
Exciting opportunity to conduct cutting-edge research in Tuberculosis drug discovery in an Academia-Industry collaboration led by Marte Dragset #CEMIR @NTNUikom linkedin.com/feed/update/urn…
NTNU Klinisk og Molekylær Medisin retweeted
One day conference on 'a healthy future' ntnu.edu/health/conference from NTNU Health - I'm looking forward to the talks and not least Precision Medicine Frontiers with @KjetilTasken @stinekorreman and @MattijsElschot!! @NTNUhelse @NTNUikom
NTNU Klinisk og Molekylær Medisin retweeted
Are you interested in joining our research group @NTNUikom in Trondheim, and work and work on tomorrow's biomarkers for cancer therapy? We have a PhD just opened in bioinformatics on scRNA on cancer cells and patient tumour derived spheroids. jobbnorge.no/en/available-jo…
We have a vacancy for one PhD candidate in #bioinformatics at @NTNUikom within the field of computational precision medicine, and with a focus on multi-omics data integration for cancer signalling modelling jobbnorge.no/en/available-jo… @asmundflobak
NTNU Klinisk og Molekylær Medisin retweeted
We wrote a preview on the latest article by @LehtinenLab on choroid plexus targeted therapies against post-hemorrhagic hydrocephalus with @InyoungJeong2. It is out now available in Neuron. doi.org/10.1016/j.neuron.202…
Online now: Choroid plexus-targeted NKCC1 overexpression to treat post-hemorrhagic hydrocephalus
Check out this study led by @LehtinenLab @HMS_Neuro @BostonChildrens @NeuroCellPress #ASGCT23 hubs.li/Q01Q0MV90
NTNU Klinisk og Molekylær Medisin retweeted
Preprint alert! biorxiv.org/content/10.1101/…
Cilia come in many different shapes and structures. #Cilia of olfactory sensory neurons are particularly fascinating: they are super long (see picture below) and have properties of both primary and motile cilia. What makes them so special?
We have a vacancy for a PhD candidate in #SpatialTranscriptomics @NTNUikom on the project Identifying small-cell lung cancer patients responding to immune checkpoint inhibitors jobbnorge.no/en/available-jo… #SmallCellLungCancer
Mødre som føder svært premature barn, har et sterkt behov for å få bekreftet at barnet er livskraftig. Det oppnås best gjennom tidlig hudkontakt. sykepleien.no/fag/2023/04/ti… @NTNUikom @TSykepleien
NTNU Klinisk og Molekylær Medisin retweeted
Finally, our story on #endoglin and #BMP9 signaling with the group of @wli225 is out. This is also the first 1st author paper of PhD student Clara Andersson-Rusch @NTNUikom @StOlavshospital @NTNUNaturalSci
Excited to share our new paper on #endoglin and #BMP9 signalling, in collaboration with @TorilHol, funded by @TheBHF. @HLRI_Cambridge, @Cambridgecardio, , @MedCambridge, #TGF-beta.
doi.org/10.1038/s41598-023-3…
Svært interessant sak i A-magasinet om hvordan @Magnarbjoras ved @NTNUikom gir Julian og barn som ham et håp: aftenposten.no/amagasinet/i/…
We have vacancies for two PhD candidates in the AICAN group. The candidates will develop and validate machine learning techniques for automatic assessment of digital breast and lung cancer tissue sections. jobbnorge.no/en/available-jo… @NTNUikom ntnu.edu/ikom/aican#/view/ab… @ingerid_r
The birth prevalence of dyskinetic CP in Norway was low and decreased significantly from 1996 to 2015. It suggests that general improvements in antenatal, obstetric, and neonatal care may prevent some cases of dyskinetic CP onlinelibrary.wiley.com/doi/… @NTNUikom
Professor Marit Otterlei ved @NTNUikom har laget en helt ny type kreftmedisin. Ingen lignende medisiner har kommet så langt i utviklingen på verdensbasis. gemini.no/2023/03/dodssyke-p…
